Page last updated: 2024-11-04

sulfasalazine and Hereditary Autoinflammation Diseases

sulfasalazine has been researched along with Hereditary Autoinflammation Diseases in 3 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, X1
Wu, D1
Li, J1
Shen, M1
Zhang, W1
Estephan, M1
Yao, Q2
Springer, J1
Shen, B1

Reviews

1 review available for sulfasalazine and Hereditary Autoinflammation Diseases

ArticleYear
A Chinese case series of Yao syndrome and literature review.
    Clinical rheumatology, 2018, Volume: 37, Issue:12

    Topics: Adult; Asian People; China; Female; Fever; Foot; Genetic Variation; Genotype; Glucocorticoids; Hered

2018

Other Studies

2 other studies available for sulfasalazine and Hereditary Autoinflammation Diseases

ArticleYear
Case of NOD2-Associated Autoinflammatory Disease Successfully Treated With Sulfasalazine.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2017, Volume: 23, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Hereditary Autoinflammatory Diseases; Humans; Male; Nod2 Si

2017
A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory Disease.
    The American journal of medicine, 2017, Volume: 130, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Huma

2017